NeoVista Secures $33,784,545 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    38875 Cherry St. Newark, CA 94560
  • Company Description
    NeoVista, Inc. is developing a novel therapy to treat wet Age-Related Macular Degeneration (AMD) utilizing a Strontium-90 isotope. The delivery is made through a minimally invasive surgical procedure. The NeoVista, Inc.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy